BACCX | VENAX | BACCX / VENAX | |
Total Expense Ratio | 2.04 | 0.09 | 2,267% |
Annual Report Gross Expense Ratio | 2.10 | 0.09 | 2,333% |
Fund Existence | 20 years | 21 years | - |
Gain YTD | 6.667 | 3.140 | 212% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 286M | 8.11B | 4% |
Annual Yield % from dividends | 1.73 | 3.43 | 51% |
Returns for 1 year | 3.10 | -0.19 | -1,663% |
Returns for 3 years | 22.25 | 17.37 | 128% |
Returns for 5 years | 133.07 | 142.41 | 93% |
Returns for 10 years | 28.29 | 14.94 | 189% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JPIVX | 30.62 | 0.03 | +0.10% |
JPMorgan U.S. Applied Data Sci Val I | |||
SCPIX | 48.89 | -0.11 | -0.22% |
DWS S&P 500 Index S | |||
RSEFX | 13.93 | -0.04 | -0.29% |
Royce Small-Cap Special Equity Svc | |||
JDITX | 15.79 | -0.07 | -0.44% |
JHancock Disciplined Value Intl R4 | |||
RGRLX | 10.97 | -0.08 | -0.72% |
RBC Global Equity Leaders R6 |